Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)
China
· Delayed Price · Currency is CNY
11.57
-0.05 (-0.43%)
Jan 3, 2025, 3:00 PM CST
Shanghai Shyndec Pharmaceutical Revenue
Shanghai Shyndec Pharmaceutical had revenue of 2.63B CNY in the quarter ending September 30, 2024, a decrease of -3.10%. This brings the company's revenue in the last twelve months to 11.50B, down -7.26% year-over-year. In the year 2023, Shanghai Shyndec Pharmaceutical had annual revenue of 12.07B, down -6.86%.
Revenue (ttm)
11.50B
Revenue Growth
-7.26%
P/S Ratio
1.35
Revenue / Employee
990.81K
Employees
11,608
Market Cap
15.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.07B | -889.39M | -6.86% |
Dec 31, 2022 | 12.96B | -985.63M | -7.07% |
Dec 31, 2021 | 13.94B | 1.39B | 11.06% |
Dec 31, 2020 | 12.56B | 357.17M | 2.93% |
Dec 31, 2019 | 12.20B | 878.33M | 7.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |